Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

October 31, 2005

Study Completion Date

February 28, 2006

Conditions
Colorectal Cancer
Interventions
DRUG

capecitabine and oxaliplatin + cetuximab

cetuximab

DRUG

capecitabine and oxaliplatin

capecitabine and oxaliplatin without cetuximab

Trial Locations (18)

3600

Regionalspital, Thun

4310

Praxis Dr. Beretta, Rheinfelden

5001

Kantonspital Aarau, Aarau

5404

Praxis Dr. Streit, Baden

8063

City Hospital Triemli, Zurich

CH-5001

Hirslanden Klinik Aarau, Aarau

CH-5404

Kantonsspital Baden, Baden

CH-4016

Saint Claraspital AG, Basel

CH-4031

Universitaetsspital-Basel, Basel

CH-3010

Inselspital Bern, Bern

CH-4101

Kantonsspital Bruderholz, Bruderholz

CH-7000

Spitaeler Chur AG, Chur

CH-1211

Hopital Cantonal Universitaire de Geneve, Geneva

CH-4410

Kantonsspital, Liestal

CH-6900

Ospedale Civico, Lugano

CH-9007

Kantonsspital - St. Gallen, Sankt Gallen

CH-8037

Stadtspital Waid, Zurich

CH-8091

UniversitaetsSpital Zuerich, Zurich

All Listed Sponsors
lead

Swiss Cancer Institute

OTHER

NCT00227734 - Capecitabine and Oxaliplatin With or Without Cetuximab in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery | Biotech Hunter | Biotech Hunter